Baird Financial Group Inc. increased its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 132.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 290,659 shares of the real estate investment trust's stock after purchasing an additional 165,535 shares during the quarter. Baird Financial Group Inc.'s holdings in Healthpeak Properties were worth $5,877,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mercer Global Advisors Inc. ADV lifted its stake in shares of Healthpeak Properties by 29.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 38,379 shares of the real estate investment trust's stock worth $778,000 after buying an additional 8,726 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in Healthpeak Properties by 15.6% in the 4th quarter. Ameriprise Financial Inc. now owns 6,671,491 shares of the real estate investment trust's stock worth $134,028,000 after acquiring an additional 902,171 shares during the period. BNP Paribas Financial Markets acquired a new position in Healthpeak Properties during the 4th quarter worth $29,580,000. Benjamin Edwards Inc. lifted its position in Healthpeak Properties by 23.1% during the 4th quarter. Benjamin Edwards Inc. now owns 32,700 shares of the real estate investment trust's stock worth $663,000 after acquiring an additional 6,141 shares during the last quarter. Finally, Brevan Howard Capital Management LP boosted its holdings in Healthpeak Properties by 66.7% during the fourth quarter. Brevan Howard Capital Management LP now owns 19,031 shares of the real estate investment trust's stock valued at $386,000 after acquiring an additional 7,616 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.
Insiders Place Their Bets
In related news, CEO Scott M. Brinker acquired 1,490 shares of the stock in a transaction dated Monday, August 4th. The shares were bought at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the purchase, the chief executive officer owned 211,906 shares in the company, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders purchased 8,783 shares of company stock worth $150,129 over the last 90 days. 0.23% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on DOC shares. Morgan Stanley dropped their price objective on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research note on Friday, August 22nd. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Wells Fargo & Company reduced their price objective on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 27th. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $18.00 price objective (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Finally, Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Seven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Healthpeak Properties presently has an average rating of "Moderate Buy" and a consensus target price of $21.50.
Get Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Performance
DOC stock traded down $0.10 during midday trading on Wednesday, hitting $17.97. The stock had a trading volume of 5,551,620 shares, compared to its average volume of 6,147,351. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.26. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The stock has a 50-day simple moving average of $17.76 and a 200 day simple moving average of $18.22. The firm has a market capitalization of $12.48 billion, a price-to-earnings ratio of 74.86, a P/E/G ratio of 2.32 and a beta of 1.07.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business's revenue for the quarter was down .2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The firm also recently declared a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were paid a dividend of $0.1017 per share. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.8%. Healthpeak Properties's dividend payout ratio (DPR) is currently 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.